Immunopathology of COVID-19 and its implications in the development of rhino-orbital-cerebral mucormycosis: a major review

References

• Gamaletsou MN, Sipsas NV, Roilides E. Rhino-orbital-cerebral mucormycosis. Curr Infect Dis Rep. 2012;14(4):423–434. doi:10.1007/s11908-012-0272-6.
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Das A, Sharma A, Panda N, Das S, Gupta KL, et al. Ten Years’ experience in zygomycosis at a tertiary care centre in India. J Infect. 2001;42(4):261–266. doi:10.1053/jinf.2001.0831.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Edwards J, Ibrahim A. Novel perspectives on mucormycosis. Pathophysiology, presentation and management. Clin Microbiol Rev. 2005;18(3):556–569. doi:10.1128/CMR.18.3.556-569.2005.
   PubMed Web of Science ®Google Scholar
• Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycete in human disease. Clin Microbiol Rev. 2000;13(2):236–301. doi:10.1128/CMR.13.2.236.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. 2020. https://idf.org/our-network/regionsmembers/south-eastasia/members/94-india.html. Accessed February 28, 2021
   Google Scholar
• Sugar AM. Agents of mucormycosis and related species. In: Mandell G, Bennett J, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, PA: Elsevier; 2005:2979.
   Google Scholar
• Ibrahim AS, Je E, Sg F. Zygomycosis. In: Dismukes W, Pappas P, Sobel J, eds. Clinical Mycology. New York, NY: Oxford University Press; 2003:241–251.
   Google Scholar
• Zhou P, Liu Z, Chen Y, Xiao Y, Huang X, Fan XG. Bacterial and fungal infections in COVID-19 patients: a matter of concern. Infect Control Hosp Epidemiol. 2020;41(9):1124–1125. doi:10.1017/ice.2020.156.
   PubMed Web of Science ®Google Scholar
• Chen X, Liao B, Cheng L, Peng X, Xu X, Li Y, et al. The microbial coinfection in COVID-19. Appl Microbiol Biotechnol. 2020;104(18):7777–7785. doi:10.1007/s00253-020-10814-6.
   PubMed Web of Science ®Google Scholar
• White PL, Dhillon R, Hughes H, Wise MP, Backx M. COVID-19 and fungal infection: the need for a strategic approach. Lancet Microbe. 2020;1(5):e196. doi:10.1016/S2666-5247(20)30127-0.
   PubMedGoogle Scholar
• Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus. 2020;12:e10726.
   PubMed Web of Science ®Google Scholar
• Waizel-Haiat S, Guerrero-Paz JA, Sanchez-Hurtado L, Calleja-Alarcon S, Romero-Gutierrez L. A case of fatal rhino-orbital Mucormycosis associated with new onset diabetic ketoacidosis and COVID-19. Cureus. 2021;13(2):e13163. doi:10.7759/cureus.13163.
   PubMed Web of Science ®Google Scholar
• Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: a tale of two pathogens. Indian J Ophthalmol. 2021;69(2):244–252. doi:10.4103/ijo.IJO_3774_20.
   PubMed Web of Science ®Google Scholar
• Natesan SK, Chandrasekar PH. Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations. Infect Drug Resist. 2016;9:291–300. doi:10.2147/IDR.S102207.
   PubMed Web of Science ®Google Scholar
• Brosnahan SB, Jonkman AH, Kugler MC, Munger JS, Kaufman DA. COVID-19 and respiratory system disorders: current knowledge, future clinical and translational research questions. Arterioscler Thromb Vasc Biol. 2020;40(11):2586–2597. doi:10.1161/ATVBAHA.120.314515.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang Y, Wu L, Niu S, Song C, Zhang Z, et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 2020;181(4):894–904. doi:10.1016/j.cell.2020.03.045.
   PubMed Web of Science ®Google Scholar
• Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Life Sci. 2020;63(3):457–460. doi:10.1007/s11427-020-1637-5.
   Web of Science ®Google Scholar
• Koparal M, Kurt E, Altuntas EE, Dogan F. Assessment of mucociliary clearance as an indicator of nasal function in patients with COVID-19: a cross-sectional study. Eur Arch Otorhinolaryngol. 2020;13:1–6.
   Google Scholar
• Chilvers MA, McKean M, Rutman A, Myint BS, Silverman M, O’-Callaghan C. The effects of coronavirus on human nasal ciliated respiratory epithelium. Eur Respir J. 2001;18(6):965–970. doi:10.1183/09031936.01.00093001.
   PubMed Web of Science ®Google Scholar
• Bouchara JP, Oumeziane NA, Lissitzky JC, Larcher G, Tronchin G, Chabasse D. Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components. Eur J Cell Biol. 1996;70:76–83.
   PubMed Web of Science ®Google Scholar
• Huang Y, Yang C, Xu XF, Xu W, Liu SW. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin. 2020;3:1–9.
   Google Scholar
• Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11(1):1620. doi:10.1038/s41467-020-15562-9.
   PubMed Web of Science ®Google Scholar
• Shang J, Ye G, Shi K. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581(7807):221–224. doi:10.1038/s41586-020-2179-y.
   PubMed Web of Science ®Google Scholar
• Versteeg GA, Ps VDN, Bredenbeek PJ, Spaan WJM. The coronavirus spike protein induces endoplasmic reticulum stress and upregulation of intracellular chemokine mRNA concentrations. J Virol. 2007;81(20):10981–10990. doi:10.1128/JVI.01033-07.
   PubMed Web of Science ®Google Scholar
• Chu H, Chan CM, Zhang X, Wang Y, Yuan S, Zhou J, et al. Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells. J Biol Chem. 2018;293(30):11709–11726. doi:10.1074/jbc.RA118.001897.
   PubMed Web of Science ®Google Scholar
• Sabirli R, Koseler A, Goren T, Turkcuer I, Kurt O. High GRP78 levels in Covid-19 infection: a case-control study. Life Sci. 2021;265:118781. doi:10.1016/j.lfs.2020.118781.
   PubMed Web of Science ®Google Scholar
• Köseler A, Sabirli R, Gören T, Türkçüer İ, Kurt Ö. Endoplasmic reticulum stress markers in SARS-COV-2 infection and pneumonia: case-control study. In Vivo. 2020;34(3 suppl):1645–1650. doi:10.21873/invivo.11956.
   PubMedGoogle Scholar
• Liu M, Spellberg B, Phan QT, Fu Y, Fu Y, Lee AS, et al. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J Clin Invest. 2010;120(6):1914–1924. doi:10.1172/JCI42164.
   PubMed Web of Science ®Google Scholar
• Alqarihi A, Gebremariam T, Gu Y, Swidergall M, Alkhazraji S, Soliman SSM, et al. GRP78 and integrins play different roles in host cell invasion during mucormycosis. MBio. 2020;2(11):01087–20.
   Google Scholar
• Feng Z, Diao B, Wang R, Wang G, Wang C, Tan Y, et al. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes. medRxiv; 2020.
   Google Scholar
• Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):1–13. doi:10.1038/s41586-020-2286-9.
   Web of Science ®Google Scholar
• Dirk BS, Pawlak EN, Johnson AL, Van Nynatten LR, Jacob RA, Heit B, et al. HIV-1 Nef sequesters MHC-I intracellularly by targeting early stages of endocytosis and recycling. Sci Rep. 2016;6(1):37021. doi:10.1038/srep37021.
   PubMedGoogle Scholar
• Dirk BS, Heit B, Dikeakos JD. Visualizing interactions between HIV-1 nef and host cellular proteins using ground-state depletion microscopy. AIDS Res Hum Retroviruses. 2015;31(7):671–672. doi:10.1089/aid.2014.0333.
   PubMed Web of Science ®Google Scholar
• Ghuman H, Voelz K. Innate and adaptive immunity to mucorales. J Fungi (Basel). 2017;3(3):48. doi:10.3390/jof3030048.
   PubMedGoogle Scholar
• López-Muñoz A, Nicolás FE, García-Moreno D, Pérez-Oliva AB, Navarro-Mendoza MI, Hernández-Oñate MA, et al. An adult zebrafish model reveals that Mucormycosis induces apoptosis of infected macrophages. Sci Rep. 2018;8(1):12802. doi:10.1038/s41598-018-30754-6.
   PubMedGoogle Scholar
• Waldorf AR, Levitz SM, Diamond RD. In vivo broncho alveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis. 1984;150:752–760.
   PubMed Web of Science ®Google Scholar
• Lamichhane PP, Samarasinghe AE. The role of innate leukocytes during influenza virus infection. J Immunol Res. 2019;12:8028725.
   Google Scholar
• Rosales C. Neutrophils at the crossroads of innate and adaptive immunity. J Leukoc Biol. 2020;108(1):377–396. doi:10.1002/JLB.4MIR0220-574RR.
   PubMed Web of Science ®Google Scholar
• Barr FD, Ochsenbauer C, Wira CR, Rodriguez-Garcia M. Neutrophil extracellular traps prevent HIV infection in the female genital tract. Mucosal Immunol. 2018;11(5):1420–1428. doi:10.1038/s41385-018-0045-0.
   PubMed Web of Science ®Google Scholar
• Ruan Q, Yang K, Wang W, Jiang L, Song J. Correction to: clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(6):1294–1297. doi:10.1007/s00134-020-06028-z.
   PubMed Web of Science ®Google Scholar
• Min CK, Cheon S, Ha NY, Sohn KM, Kim Y, Aigerim A, et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep. 2016;6(1):25359. doi:10.1038/srep25359.
   PubMedGoogle Scholar
• Jorch SK, Kubes P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat Med. 2017;23(3):279–287. doi:10.1038/nm.4294.
   PubMed Web of Science ®Google Scholar
• Coutinho HD, Lôbo KM, Bezerra DA, Lôbo I. Peptides and proteins with antimicrobial activity. Indian J Pharmacol. 2008;40(1):3–9. doi:10.4103/0253-7613.40481.
   PubMed Web of Science ®Google Scholar
• Chamilos G, Lewis RE, Lamaris G, Walsh TJ, Kontoyiannis DP. Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage. Antimicrob Agents Chemother. 2008;52(2):722–724. doi:10.1128/AAC.01136-07.
   PubMed Web of Science ®Google Scholar
• Chinn RY, Diamond RD. Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis. Infect Immun. 1982;38(3):1123–1129. doi:10.1128/iai.38.3.1123-1129.1982.
   PubMed Web of Science ®Google Scholar
• Patel A, Agarwal R, Rudramurthy SM, Shevkani M, Xess I, Sharma R, et al. Multicenter epidemiologic study of coronavirus disease–associated Mucormycosis, India. Emerg Infect Dis. 2021 Jun 4;27(9):2349–2359. doi:10.3201/eid2709.210934. Epub ahead of print. PMID: 34087089.
   PubMed Web of Science ®Google Scholar
• Watson CN, Kerrigan SW, Cox D, Henderson IR, Watson SP, Arman M. Human platelet activation by Escherichia coli: roles for FcγRIIA and integrin αIIbβ3. Platelets. 2016;27(6):535–540. doi:10.3109/09537104.2016.1148129.
   PubMed Web of Science ®Google Scholar
• van Eeden C, Khan L, Osman MS, Cohen Tervaert JW. Natural killer cell dysfunction and its role in COVID-19. Int J Mol Sci. 2020;21(17):6351. doi:10.3390/ijms21176351.
   PubMed Web of Science ®Google Scholar
• Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834–847. doi:10.1002/ajh.25829.
   PubMed Web of Science ®Google Scholar
• Rao VUS, Arakeri G, Subash A, Rao J, Jadhav S, Suhail Sayeed M, et al. COVID-19: loss of bridging between innate and adaptive immunity? Med Hypotheses. 2020;144:109861. doi:10.1016/j.mehy.2020.109861.
   PubMed Web of Science ®Google Scholar
• Law HK, Cheung CY, Ng HY, Sia SF, Chan YO, Luk W, et al. Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells. Blood. 2005;106(7):2366–2374. doi:10.1182/blood-2004-10-4166.
   PubMed Web of Science ®Google Scholar
• Perkhofer S, Kainzner B, Kehrel BE, Dierich MP, Nussbaumer W, Lass-Flörl C. Potential antifungal effects of human platelets against zygomycetes in vitro. J Infect Dis. 2009;200(7):1176–1179. doi:10.1086/605607.
   PubMed Web of Science ®Google Scholar
• Ibrahim AS, Spellberg B, Edwards J Jr. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis. 2008;21(6):620–625. doi:10.1097/QCO.0b013e3283165fd1.
   PubMed Web of Science ®Google Scholar
• Voelz K, Gratacap RL, Wheeler RT. A zebrafish larval model reveals early tissue-specific innate immune responses to Mucor circinelloides. Dis Model Mech. 2015;8(11):1375–1388. doi:10.1242/dmm.019992.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5.
   PubMed Web of Science ®Google Scholar
• Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 2014;6(4):748–773. doi:10.1039/C3MT00347G.
   PubMed Web of Science ®Google Scholar
• Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol. 2017;29(9):401–409. doi:10.1093/intimm/dxx031.
   PubMed Web of Science ®Google Scholar
• Rouault TA. Mitochondrial iron overload: causes and consequences. Curr Opin Genet Dev. 2016;38:31–37. doi:10.1016/j.gde.2016.02.004.
   PubMed Web of Science ®Google Scholar
• Starkov AA. The role of mitochondria in reactive oxygen species metabolism and signaling. Ann NY Acad Sci. 2008;1147(1):37–52. doi:10.1196/annals.1427.015.
   PubMedGoogle Scholar
• Herst PM, Rowe MR, Carson GM, Berridge MV. Functional mitochondria in health and disease. Front Endocrinol (Lausanne). 2017;8:296. doi:10.3389/fendo.2017.00296.
   PubMed Web of Science ®Google Scholar
• Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13(2):148–159. doi:10.1038/cmi.2015.95.
   PubMed Web of Science ®Google Scholar
• Naik E, Dixit VM. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med. 2011;208(3):417–420. doi:10.1084/jem.20110367.
   PubMed Web of Science ®Google Scholar
• Jouihan HA, Cobine PA, Cooksey RC, Hoagland EA, Boudina S, Abel ED. Iron-Mediated inhibition of mitochondrial manganese uptake mediates mitochondrial dysfunction in a mouse model of hemochromatosis. Mol Med. 2008;14(3–4):98–108. doi:10.2119/2007-00114.Jouihan.
   PubMed Web of Science ®Google Scholar
• Aguirre JD, Culotta VC. Battles with iron: manganese in oxidative stress protection. J Biol Chem. 2012;287(17):13541–13548. doi:10.1074/jbc.R111.312181.
   PubMed Web of Science ®Google Scholar
• Park D, Han CZ, Elliott MR, Kinchen JM, Trampont PC, Das S, et al. Continued clearance of apoptotic cells critically depends on the phagocyte UCP2 protein. Nature. 2011;477(7363):220–224. doi:10.1038/nature10340.
   PubMed Web of Science ®Google Scholar
• Janssen E, Tabeta K, Barnes MJ, Rutschmann S, McBride S, Bahjat KS, et al. Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway. Immunity. 2006;24(6):787–799. doi:10.1016/j.immuni.2006.03.024.
   PubMed Web of Science ®Google Scholar
• Navarro A, Boveris A. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol. 2007;292(2):C670–686. doi:10.1152/ajpcell.00213.2006.
   PubMed Web of Science ®Google Scholar
• Chougnet CA, Thacker RI, Shehata HM, Hennies CM, Lehn MA, Lages CS, et al. Loss of phagocytic and antigen cross-presenting capacity in aging dendritic cells is associated with mitochondrial dysfunction. J Immunol. 2015;195(6):2624–2632. doi:10.4049/jimmunol.1501006.
   PubMed Web of Science ®Google Scholar
• LeBlanc DM, Barousse MM, Pl F Jr. Role for dendritic cells in immunoregulation during experimental vaginal candidiasis. Infect Immun. 2006;74(6):3213–3221. doi:10.1128/IAI.01824-05.
   PubMed Web of Science ®Google Scholar
• Eapen MS, Sharma P, Sohal SS. Mitochondrial dysfunction in macrophages: a key to defective bacterial phagocytosis in COPD. Eur Respir J. 2019;54(4):1901641. doi:10.1183/13993003.01641-2019.
   PubMed Web of Science ®Google Scholar
• Nicolás FE, Murcia L, Navarro E, Navarro-Mendoza MI, Pérez-Arques C, Garre V. Mucorales species and macrophages. J Fungi (Basel). 2020;6(2):94. doi:10.3390/jof6020094.
   PubMedGoogle Scholar
• Roilides E, Antachopoulos C, Simitsopoulou M. Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs. Mycoses. 2014;57:40–47. doi:10.1111/myc.12236.
   PubMed Web of Science ®Google Scholar
• Morikawa K, Oseko F, Morikawa S. A role for ferritin in hematopoiesis and the immune system. Leuk Lymphoma. 1995;18(5–6):429–433. doi:10.3109/10428199509059641.
   PubMed Web of Science ®Google Scholar
• Govender N, Khaliq OP, Moodley J, and Naicker T. Insulin resistance in COVID-19 and diabetes. Prim Care Diabetes. 2021 Aug;15(4):629–634. doi:10.1016/j.pcd.2021.04.004.
   PubMed Web of Science ®Google Scholar
• Vallianou NG, Evangelopoulos A, Kounatidis D, Stratigou T, Christodoulatos GS, Karampela I, et al. Diabetes mellitus and SARS-CoV-2 infection: pathophysiologic mechanisms and implications in management. Curr Diabetes Rev. 2020;31.
   Web of Science ®Google Scholar
• Rubino F, Amiel SA, Zimmet P, Alberti G, Bornstein S, Eckel RH, et al. New-onset diabetes in Covid-19. N Engl J Med. 2020;383(8):789–790. doi:10.1056/NEJMc2018688.
   PubMed Web of Science ®Google Scholar
• Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068–1077.e3. doi:10.1016/j.cmet.2020.04.021.
   PubMed Web of Science ®Google Scholar
• Holman N, Knighton P, Kar P, O’-Keefe J, Curley M, Weaver A, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8(10):823–833. doi:10.1016/S2213-8587(20)30271-0.
   PubMed Web of Science ®Google Scholar
• Hollstein T, Schulte DM, Schulz J, Glück A, Ziegler AG, Bonifacio E, et al. Autoantibody-Negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report. Nat Metab. 2020;2(10):1021–1024. doi:10.1038/s42255-020-00281-8.
   PubMedGoogle Scholar
• Chee YJ, Ng SJH, Yeoh E. Diabetic ketoacidosis precipitated by COVID-19 in a patient with newly diagnosed diabetes mellitus. Diabetes Res Clin Pract. 2020;164:108166. doi:10.1016/j.diabres.2020.108166.
   PubMed Web of Science ®Google Scholar
• Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab. 2020;22(10):1935–1941. doi:10.1111/dom.14057.
   PubMed Web of Science ®Google Scholar
• Ren H, Yang Y, Wang F, Yan Y, Shi X, Dong K, et al. Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19. Cardiovasc Diabetol. 2020;19(1):58. doi:10.1186/s12933-020-01035-2.
   PubMed Web of Science ®Google Scholar
• Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest. 1989;84(1):205–213. doi:10.1172/JCI114142.
   PubMed Web of Science ®Google Scholar
• Eketunde AO, Mellacheruvu SP, Oreoluwa P. A review of postmortem findings in patients with COVID-19. Cureus. 2020;12:e9438.
   PubMedGoogle Scholar
• Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-Converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586–590. doi:10.1007/s00134-020-05985-9.
   PubMed Web of Science ®Google Scholar
• Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE2 expression in Pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol. 2020;18(9):2128–2130.e2. doi:10.1016/j.cgh.2020.04.040.
   PubMed Web of Science ®Google Scholar
• Reddy PK, Kuchay MS, Mehta Y, Mishra SK. Diabetic ketoacidosis precipitated by COVID-19: a report of two cases and review of literature. Diabetes Metab Syndr. 2020;14(5):1459–1462. doi:10.1016/j.dsx.2020.07.050.
   PubMed Web of Science ®Google Scholar
• Nair AG, Adulkar NG, D’-Cunha L, Rao PR, Bradoo RA, Bapaye MM, et al. Rhino-Orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients. Orbit. 2021;40(6):499–504. doi:10.1080/01676830.2021.1960382.
   PubMed Web of Science ®Google Scholar
• Dave TV, Nair AG, Hegde R, Vithalani N, Desai S, Adulkar N, et al. Clinical presentations, management and outcomes of rhino-orbital-cerebral Mucormycosis (ROCM) following COVID-19: a multi-centric study. Ophthalmic Plast Reconstr Surg. 2021;37(5):488–495. doi:10.1097/IOP.0000000000002030.
   PubMed Web of Science ®Google Scholar
• Tater D, Tepaut B, Bercovici JP, Youinou P. Polymorphonuclear cell derangements in type I diabetes. Horm Metab Res. 1987;19(12):642–647. doi:10.1055/s-2007-1011899.
   PubMed Web of Science ®Google Scholar
• Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, et al. Impaired leucocyte functions in diabetic patients. Diabet Med. 1997;14(1):29–34. doi:10.1002/(SICI)1096-9136(199701)14:1<29:AID-DIA300>3.0.CO;2-V.
   PubMed Web of Science ®Google Scholar
• Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care. 1992;15(2):256–260. doi:10.2337/diacare.15.2.256.
   PubMed Web of Science ®Google Scholar
• Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. J Res Med Sci. 2014;19:164–174.
   PubMed Web of Science ®Google Scholar
• Van Asbeck BS, Marx JJ, Struyvenberg A, Verhoef J. Functional defects in phagocytic cells from patients with iron overload. J Infect. 1984;8(3):232–240. doi:10.1016/S0163-4453(84)93955-0.
   PubMed Web of Science ®Google Scholar
• Garner B, Li W, Roberg K, Brunk UT. On the cytoprotective role of ferritin in macrophages and its ability to enhance lysosomal stability. Free Radic Res. 1997;27(5):487–500. doi:10.3109/10715769709065788.
   PubMed Web of Science ®Google Scholar
• Carrasco-Marín E, Alvarez-Domínguez C, López-Mato P, Martínez-Palencia R, Leyva-Cobián F. Iron salts and iron-containing porphyrins block presentation of protein antigens by macrophages to MHC class II-restricted T cells. Cell Immunol. 1996;171(2):173–185. doi:10.1006/cimm.1996.0192.
   PubMed Web of Science ®Google Scholar
• Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes. 1982;31(12):1109–1114. doi:10.2337/diacare.31.12.1109.
   PubMed Web of Science ®Google Scholar
• Husain S, Alexander BD, Munoz P, Avery RK, Houston S, Pruett T, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis. 2003;37(2):221–229. doi:10.1086/375822.
   PubMed Web of Science ®Google Scholar
• Boelaert JR, Fenves AZ, Coburn JW. Registry on mucormycosis in dialysis patients. J Infect Dis. 1989;160(5):914. doi:10.1093/infdis/160.5.914.
   PubMed Web of Science ®Google Scholar
• Boelaert JR, Fenves AZ, Coburn JW. Mucormycosis among patients on dialysis. New Engl J Med. 1989;321:190–191.
   PubMed Web of Science ®Google Scholar
• Aasa R, Malmstroem BG, Saltman P. The specific binding of iron(iii) and copper(ii) to transferrin and conalbumin. Biochim Biophys Acta. 1963, September 24;75:203–222. doi:10.1016/0006-3002(63)90599-7.
   PubMedGoogle Scholar